Free Trial

M�nchener R�ckversicherungs-Gesellschaft (MURGY) Stock Forecast & Price Target

M�nchener R�ckversicherungs-Gesellschaft logo
$13.19 -0.03 (-0.23%)
As of 08/1/2025 03:59 PM Eastern

M�nchener R�ckversicherungs-Gesellschaft - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
5
Buy
1

Based on 6 Wall Street analysts who have issued ratings for M�nchener R�ckversicherungs-Gesellschaft in the last 12 months, the stock has a consensus rating of "Hold." Out of the 6 analysts, 5 have given a hold rating, and 1 has given a strong buy rating for MURGY.

Consensus Price Target

N/A

Get the Latest News and Ratings for MURGY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for M�nchener R�ckversicherungs-Gesellschaft and its competitors.

Sign Up

MURGY Analyst Ratings Over Time

TypeCurrent Forecast
8/2/24 to 8/2/25
1 Month Ago
7/3/24 to 7/3/25
3 Months Ago
5/4/24 to 5/4/25
1 Year Ago
8/3/23 to 8/2/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
N/A
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
N/A
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Hold
Hold
Hold
N/A

MURGY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MURGY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

M�nchener R�ckversicherungs-Gesellschaft Stock vs. The Competition

TypeM�nchener R�ckversicherungs-GesellschaftFinance CompaniesS&P 500
Consensus Rating Score
2.33
2.54
2.53
Consensus RatingHoldModerate BuyModerate Buy
Predicted UpsideN/A25.79% Upside14.62% Upside
News Sentiment Rating
Neutral News

See Recent MURGY News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/6/2025Keefe, Bruyette & Woods
5 of 5 stars
D. Satkauskas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Moderate Sell
4/28/2025Hsbc Global Res
0 of 5 stars
F. Lakhani
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
3/24/2025The Goldman Sachs Group
3 of 5 stars
A. Baker
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
1/28/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
I. Bokhmat
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
12/19/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
W. Hardcastle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
10/25/2024Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Huttner
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
10/21/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 04:19 AM ET.


Should I Buy M�nchener R�ckversicherungs-Gesellschaft Stock? MURGY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 29, 2025. Please send any questions or comments about these M�nchener R�ckversicherungs-Gesellschaft pros and cons to contact@marketbeat.com.

M�nchener R�ckversicherungs-Gesellschaft
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Münchener Rückversicherungs-Gesellschaft Aktienges:

  • The current stock price is around $13.02, which may present a buying opportunity for investors looking for value in the insurance and reinsurance sector.
  • Münchener Rückversicherungs-Gesellschaft Aktienges has a diverse range of products, including advanced digital underwriting and analytics solutions, which can enhance operational efficiency and attract more clients.
  • The company has a strong presence in the life and health reinsurance market, offering innovative solutions that cater to evolving consumer needs, potentially leading to increased market share.
  • With a focus on consulting services and risk management, the company is well-positioned to support clients in navigating complex insurance landscapes, which can drive revenue growth.
  • Recent advancements in their product offerings, such as the MIRA digital suite, indicate a commitment to leveraging technology for better service delivery, appealing to tech-savvy clients.

M�nchener R�ckversicherungs-Gesellschaft
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Münchener Rückversicherungs-Gesellschaft Aktienges for these reasons:

  • The company has a relatively low short percentage of float, indicating limited investor confidence, which could suggest potential volatility in stock performance.
  • Recent data shows a month-to-month change in shares shorted, which may indicate fluctuating investor sentiment and uncertainty about future performance.
  • With no outstanding shares reported, the liquidity of the stock could be a concern for investors looking to enter or exit positions quickly.
  • Institutional ownership is currently at 0%, which may reflect a lack of confidence from larger investors, potentially impacting stock stability.
  • The insurance and reinsurance industry can be heavily influenced by external factors such as natural disasters and economic downturns, which may pose risks to profitability.

MURGY Forecast - Frequently Asked Questions

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for M�nchener R�ckversicherungs-Gesellschaft in the last year. There are currently 5 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" MURGY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MURGY, but not buy additional shares or sell existing shares.

According to analysts, M�nchener R�ckversicherungs-Gesellschaft's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, M�nchener R�ckversicherungs-Gesellschaft's stock had 1 downgrade by analysts.

M�nchener R�ckversicherungs-Gesellschaft has been rated by research analysts at Keefe, Bruyette & Woods in the past 90 days.

Analysts like M�nchener R�ckversicherungs-Gesellschaft less than other "finance" companies. The consensus rating for M�nchener R�ckversicherungs-Gesellschaft is Hold while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how MURGY compares to other companies.


This page (OTCMKTS:MURGY) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners